Please login to the form below
Therapy Watch expands its oncology portfolio
This month Therapy Watch Oncology will be expanding its portfolio with the addition of Squamous Cell Carcinoma of the Head and Neck (SCCHN). Therapy Watch SCCHN is part of a wider portfolio which covers Chronic Lymphocytic Leukaemia (CLL), Non-Hodgkin's Lymphoma (NHL), Melanoma, Non-Small Cell Lung Cancer (NSCLC), Prostate Cancer (PCa), Renal Cell Carcinoma.
Find out more: http://www.researchpartnership.com/news/2016/10/therapy-watch-expands-oncology-portfolio/
Company Details
Research Partnership
+44 (0)20 8069 5000
Address:
Chester House
Fulham Green
81-83 Fulham High Street
London
SW6 3JW
United Kingdom
Latest content on this profile
- Interactive infographic
- Living With: The journey from the patient’s perspective
Research Partnership
- Article: Spotlight on Mexico
- Healthcare under AMLO – One year on
Research Partnership
- News: Mandira Kar joins London Headquarters as Qualitative Research Director
Research Partnership
- Conference Live
- Global medical conferences and events calendar 2020
Research Partnership
- Announcing a change of leadership at the US Philadelphia office
Research Partnership
- Article: Market access in Brazil
- All eyes on Spinraza
Research Partnership
